Abstract
Introduction

26
Losses from infectious diseases of livestock are most easily comprehended if 27 associated with clinical signs. For example, incursion of Bovine Herpesvirus 1 (BoHV-1) 28 into a naïve population of adult dairy cows typically leads to a variety of clinical syndromes 29 described as Infectious Bovine Rhinotracheitis (IBR). These may include respiratory, ocular 30 and nervous signs, accompanied by pyrexia, infertility and abortions and associated sudden 31 decrease in milk yield (Nettleton 2007) . However, both in previously exposed groups with 32 recrudescence of virus from latently infected cattle, or in new infections of naïve animals,
33
BoHV-1 may instead lead to sub-clinical disease and insidious production losses, rather than 
46
In England and Wales, the prevalence of dairy herds endemically infected with 
51
Estimates of the direct costs of IBR to the UK farming industry have been put at up to 52 £4 million per annum (Bennett 2003) . Data on milk production impacts of BoHV-1 are 53 described by van Schaik and others (1999) in herds that experienced clinical IBR outbreaks.
54
However, milk production losses from sub-clinical disease in commercial dairy cows have 55 not been demonstrated. Bosch and others (1996, 1997) have not been studied.
66
The aim of this study was therefore to investigate the potential effect of subclinical
67
BoHV-1 infection on milk production over a two year period in a commercial UK dairy herd. 
Materials and methods
70
Study herd background
71
The data refer to an autumn-calving dairy herd of 129 pedigree Holstein cows with 72 approximate annual milk yield of 9,000 kg per cow. and these cows were found to be seropositive. Antibodies to BoHV-1 were also identified in 
BoHV-1 is an increasingly important cattle pathogen (Woodbine and others 2009).
183
The challenge in commercial dairy herds is often to develop strategies to manage higher 184 yielding cows to optimise health and productivity and selecting for robust cows with 
